MAPK9 and metabolic dysfunction-associated steatotic liver disease: MAPK signaling pathway dysfunction was involved in NAFLD; Vernia S. et al. found that liver-specific deletion of Jnk1 and Jnk2 in mice protected mice from diet-induced obesity and insulin resistance [47], while Jing.